XML 31 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1

Restatement of Financial Statements (Tables)

9 Months Ended

Sep. 30, 2017

Restatement of Financial Statements [Abstract]

Schedule of changes made to the income statement

			Three Months Ended												Nine Months Ended
			September 30, 2016												September 30, 2016
			As Reported				Adjustment				As Restated				As Reported				Adjustment				As Restated
	Net sales		$	1,384,429			$				$	1,384,429			$	4,252,704			$				$	4,252,704
	Cost of sales			942,738				(554,536	)			388,202				2,981,657				(1,713,337	)			1,268,320
	Gross Profit			441,691								996,227				1,271,047								2,984,384
	Operating expenses
	Compensation and related expenses			361,829								361,829				1,077,340								1,077,340
	Professional fees			82,608								82,608				277,282								277,282
	Marketing expenses			-				554,536				554,536				-				1,713,337				1,713,337
	General and administrative expenses			204,958								204,958				382,857								382,857
	Total operating expenses			649,395								1,203,931				1,737,479								3,450,816
	Operating Income (Loss)			(207,704	)							(207,704	)			(466,432	)							(466,432	)
	Interest (expense)			(9,992	)							(9,992	)			(15,805	)							(15,805	)
	Net Income (Loss) Before Taxes			(217,696	)							(217,696	)			(482,237	)							(482,237	)
	Deferred income tax benefit			-								-				-								-
	Net Income (Loss)			(217,696	)							(217,696	)			(482,237	)							(482,237	)
	Net income (loss) attributable to noncontrolling interests			8,955								8,955				6,439								6,439
	Net Income (loss) attributable to Immudyne, Inc.		$	(226,651	)						$	(226,651	)		$	(488,676	)						$	(488,676	)
	Basic and diluted (loss) per share attributable to Immudyne, Inc.		$	(0.01	)						$	(0.01	)		$	(0.02	)						$	(0.02	)
	Average number of common shares outstanding
	Basic			34,427,087								34,427,087				31,917,873								31,917,873
	Diluted			34,427,087								34,427,087				31,917,873								31,917,873

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22663-107794

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22658-107794

+ Details

Name:	us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration